Non-stochastic and stochastic linear indices of the 'molecular pseudograph's atom adjacency matrix':: application to 'in silico' studies for the rational discovery of new antimalarial compounds

被引:64
作者
Marrero-Ponce, Y [1 ]
Montero-Torres, A
Zaldivar, CR
Veitía, MI
Peréz, MM
Sánchez, RNG
机构
[1] Cent Univ Villas, Dept Pharm, Fac Chem Pharm, Santa Clara 54830, Villa Clara, Cuba
[2] Cent Univ Villas, Dept Drug Design, Chem Bioact Ctr, Santa Clara 54830, Villa Clara, Cuba
[3] Univ Paris 11, Ctr Etud Pharmaceut, CNRS,Biocis UMR 8076, Lab Synthese Composes Interet Biol,Fac Pharm, F-92296 Chatenay Malabry, France
[4] Univ Nacl Amazonia Peruana, LIPNAA, Iquitos 496, Peru
关键词
TOMOCOMD-CARDD software; non-stochastic and stochastic linear indices; LDA; QSAR; antimalarial compounds;
D O I
10.1016/j.bmc.2004.11.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malaria is one of the most deadly diseases, affecting million of people especially in developing countries. Because of the rapidly increasing threat worldwide of malaria epidemics multidrugs resistant to therapies, there is an urgent global need to discover new classes of antimalarial compounds. In an effort to overcome this problem, we have investigated the use of structure-based classification models for the 'rational' selection/identification or design/optimization of new lead antimalarials from virtual combinatorial data sets. In this sense, TOpological MOlecular COMputer Design strategy (TOMOCOMD approach) has been introduced in order to obtain two quantitative models for the discrimination of antimalarials. A collected data set containing 597 antimalarial compounds is presented as a helpful tool not only for theoretical chemist but for other researchers in this area. The validated models (including non-stochastic and stochastic indices) classify correctly more than 90% of compounds in both training and external prediction data sets. They showed high Matthews' correlation coefficients; 0.87 and 0.82 for training and 0.86 and 0.79 for test set. The TOMOCOMD-CARDD approach implemented in this work was successfully compared with two of the most useful models for antimalarials selection reported so far. Thus we expect that these two QSAR models can be used in the identification of previously unknown antimalarials compounds. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1293 / 1304
页数:12
相关论文
共 76 条
[1]  
ANN DC, 1997, BURGERS MED CHEM DRU, V5
[2]  
[Anonymous], 2007, ORGANIC CHEM DRUGS T
[3]  
[Anonymous], INTERNET ELECT J MOL
[4]  
[Anonymous], MOLECULES
[5]   Structure-activity relationships of the antimalarial agent artemisinin .5. Analogs of 10-deoxoartemisinin substituted at C-3 and C-9 [J].
Avery, MA ;
Mehrotra, S ;
Johnson, TL ;
Bonk, JD ;
Vroman, JA ;
Miller, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) :4149-4155
[6]   Structure-activity relationships of the antimalarial agent artemisinin .2. Effect of heteroatom substitution at O-11: Synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins [J].
Avery, MA ;
Bonk, JD ;
Chong, WKM ;
Mehrotra, S ;
Miller, R ;
Milhous, W ;
Goins, DK ;
Venkatesan, S ;
Wyandt, C ;
Khan, I ;
Avery, BA .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (26) :5038-5044
[7]   SYNTHESIS, CONFORMATIONAL-ANALYSIS, AND ANTIMALARIAL ACTIVITY OF TRICYCLIC ANALOGS OF ARTEMISININ [J].
AVERY, MA ;
GAO, FL ;
CHONG, WKM ;
HENDRICKSON, TF ;
INMAN, WD ;
CREWS, P .
TETRAHEDRON, 1994, 50 (04) :957-972
[8]   Assessing the accuracy of prediction algorithms for classification: an overview [J].
Baldi, P ;
Brunak, S ;
Chauvin, Y ;
Andersen, CAF ;
Nielsen, H .
BIOINFORMATICS, 2000, 16 (05) :412-424
[9]   In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates [J].
Basco, LK ;
Dechy-Cabaret, O ;
Ndounga, M ;
Meche, FS ;
Robert, A ;
Meunier, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1886-1888
[10]   Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues [J].
Cheng, F ;
Shen, JH ;
Luo, XM ;
Zhu, WL ;
Gu, JD ;
Ji, RY ;
Jiang, HL ;
Chen, KX .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (09) :2883-2891